Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIQ for Breakthrough Pain in Opioid-Tolerant Children
NCT00236041Phase 2Completed
- Sponsor
- Cephalon, Inc.
- Start
- Apr 2004
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of fentanyl in breakthrough pain, sponsored by Cephalon, Inc.. Started Apr 2004; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT00236041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236041.